CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 3, 1999, Pages 209-213

  Scherberich, Juergen E ^a,b   Nockher, Wolfgang A ^a  

^a KLINIKUM BOGENHAUSEN   (Germany)

^b Abteilung fur Neurologie Stroke Unit Stad Krankenhaus Munchen Harlaching   (Germany)

Author keywords

CD14 antigen; CD16 antigen; Immunomodulation; Monitoring; Monocytes

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CD14 ANTIGEN; CD16 ANTIGEN; FC RECEPTOR; GLUCOCORTICOID; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MINOR HISTOCOMPATIBILITY ANTIGEN; RECEPTOR;

BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SYSTEMIC VASCULITIS;

EID: 0032918601     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.039     Document Type: Conference Paper

References (18)

1. Ziegler-Heitbrock HWL, Ulevitch RJ. CD14: cell surface receptor and differentiation marker, Immunol Today 1993; 14:121-5.
2. + subpopulation. Immunol Today 1996; 17:424-8.
3. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392:505-9.
4. Nockher WA, Scherberich JE. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. J Immunol 1997; 158:1345-52.
5. Scherberich JE, Nockher WA. CD14 membrane expression and release of soluble CD14 (sCD14) of monocytes is downregulated by glucocorticoids in vitro and patients with acute nephritis. Nieren-u.Hochdruckkrankheiten 1996; 25:416.
6. Scherberich JE, Nockher WA. Monocyte LPS receptor (CD14), CD14+/CD16+ , HLA-DR expression and soluble CD14 (sCD14) in patients with acute and chronic infections and under acute and chronic immunosuppression. In: Faist A, editor. The immune consequences of trauma, shock and sepsis. Bologna: Monduzzi editore 1997: 339-44.
7. Nockher WA, Bergmann L, Scherberich JE. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol 1994; 98:369-74.
8. + monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 1998; 66:2787-90.
9. Nockher WA, Wigand R, Schoeppe W, Scherberich JE. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol 1994; 96:15-9.
10. Isenberg DA, Dudeney C, Williams W, Addison I, Charles S, Clarke J, et al. Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis 1987; 46:448-56.
11. Nockher WA, Scherberich JE. Monocyte cell surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int 1995; 48:1469-75.
12. Scherberich JE, Mazur A, Tauber M, Schoeppe W. Influence of HCV, HBsAg and bacterial infections on soluble CD14 (sCD14) in serum of patients on chronic hemodialysis. Nieren-u.Hochdruckkrankh 1994; 23:439.
13. Scherberich JE, Schneider J, Nockher WA, Schoeppe W. Excretion of a soluble 48 kDa monocyte membrane antigen in patients with kidney diseases. Kidney Int 1993; 43:249.
14. Jedlicka J, Segerer W, Scherberich JE. Comparative analysis of leucocyte endotoxin receptor expression in patients under CAPD or chronic haemodialysis treatment. Kidney Blood Press Res 1998; 21:199-200.
15. + monocytes by glucocorticoid therapy. Clin Exp Immunol 1998; 112:501-6.
16. Scherberich JE, Nockher WA, Teschner M, Gröne HJ. Soluble CD14 in serum and urine, monocyte CD14+/16+, HLA-DR expression, proteinuria and influx of renal tissue macrophages in patients with kidney diseases. Kidney Blood Press Res 1998; 21:147-8.
17. Baer PC, Nockher WA, Haase W, Scherberich JE. Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Kidney Int 1997; 52:1321-31.
18. Scherberich JE, Nockher WA, Baer PC. Cross-talk between activated tubular epithelia of human kidney and monocytes: a basis for target cell specific pharmacotherapy ? Nephrol Dial Transplant; In press.